| Preferred Hospice Of Missouri 423 Business Highway 60 West Box 99, Dexter, MO, 63841 | |
| (573) 614-4774 |
News Archive
Simon Fraser University professor Andy Hoffer hopes the SFU spinoff company he founded, Lungpacer Medical Inc., will help save the lives of COVID-19 patients using mechanical ventilators-and get them off more quickly, so that more ventilators can be available for all critically ill patients.
Climbing suicide rates over the past ten years have prompted three Joint Commission Sentinel Event Alerts - the most recent in February 2016 - urging health care organizations to step up screening and detection of those individuals most at risk. But due to a shortage of both time and psychiatry staff, complying with this mandate presents a challenge.
The American Heart Association, with support from the Jon Holden DeHaan Foundation, has awarded funding for three research centers to study the development and mechanisms of generating new cardiac muscle cells.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announces today the completion of patient enrolment for its first clinical trial.
› Verified 5 days ago
| Name | Preferred Hospice Of Missouri |
|---|---|
| Location | 423 Business Highway 60 West Box 99, Dexter, Missouri |
| Hospice ID | 261603 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 985 |
News Archive
Simon Fraser University professor Andy Hoffer hopes the SFU spinoff company he founded, Lungpacer Medical Inc., will help save the lives of COVID-19 patients using mechanical ventilators-and get them off more quickly, so that more ventilators can be available for all critically ill patients.
Climbing suicide rates over the past ten years have prompted three Joint Commission Sentinel Event Alerts - the most recent in February 2016 - urging health care organizations to step up screening and detection of those individuals most at risk. But due to a shortage of both time and psychiatry staff, complying with this mandate presents a challenge.
The American Heart Association, with support from the Jon Holden DeHaan Foundation, has awarded funding for three research centers to study the development and mechanisms of generating new cardiac muscle cells.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announces today the completion of patient enrolment for its first clinical trial.
› Verified 5 days ago
| NPI Number | 1548296304 |
| Organization Name | Preferred Hospice Of Missouri Llc |
| Address | 423 Business Highway 60 West Dexter, Missouri, 63841 |
| Phone Number | (573)614-4774 |
News Archive
Simon Fraser University professor Andy Hoffer hopes the SFU spinoff company he founded, Lungpacer Medical Inc., will help save the lives of COVID-19 patients using mechanical ventilators-and get them off more quickly, so that more ventilators can be available for all critically ill patients.
Climbing suicide rates over the past ten years have prompted three Joint Commission Sentinel Event Alerts - the most recent in February 2016 - urging health care organizations to step up screening and detection of those individuals most at risk. But due to a shortage of both time and psychiatry staff, complying with this mandate presents a challenge.
The American Heart Association, with support from the Jon Holden DeHaan Foundation, has awarded funding for three research centers to study the development and mechanisms of generating new cardiac muscle cells.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announces today the completion of patient enrolment for its first clinical trial.
› Verified 5 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 97.3 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 76.7 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 72.7 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 96.9 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 98.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 96.7 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Simon Fraser University professor Andy Hoffer hopes the SFU spinoff company he founded, Lungpacer Medical Inc., will help save the lives of COVID-19 patients using mechanical ventilators-and get them off more quickly, so that more ventilators can be available for all critically ill patients.
Climbing suicide rates over the past ten years have prompted three Joint Commission Sentinel Event Alerts - the most recent in February 2016 - urging health care organizations to step up screening and detection of those individuals most at risk. But due to a shortage of both time and psychiatry staff, complying with this mandate presents a challenge.
The American Heart Association, with support from the Jon Holden DeHaan Foundation, has awarded funding for three research centers to study the development and mechanisms of generating new cardiac muscle cells.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announces today the completion of patient enrolment for its first clinical trial.
› Verified 5 days ago
| Home Health Aides | 3 |
| Counselors | 3 |
| Homemakers | 0.5 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 1.75 |
| Registered Nurses | 4 |
| Other Personnel | 3 |
| Total Employees | 17.25 |
|---|
News Archive
Simon Fraser University professor Andy Hoffer hopes the SFU spinoff company he founded, Lungpacer Medical Inc., will help save the lives of COVID-19 patients using mechanical ventilators-and get them off more quickly, so that more ventilators can be available for all critically ill patients.
Climbing suicide rates over the past ten years have prompted three Joint Commission Sentinel Event Alerts - the most recent in February 2016 - urging health care organizations to step up screening and detection of those individuals most at risk. But due to a shortage of both time and psychiatry staff, complying with this mandate presents a challenge.
The American Heart Association, with support from the Jon Holden DeHaan Foundation, has awarded funding for three research centers to study the development and mechanisms of generating new cardiac muscle cells.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announces today the completion of patient enrolment for its first clinical trial.
› Verified 5 days ago
| Others | 2 |
| Total Volunteers | 2 |
|---|
News Archive
Simon Fraser University professor Andy Hoffer hopes the SFU spinoff company he founded, Lungpacer Medical Inc., will help save the lives of COVID-19 patients using mechanical ventilators-and get them off more quickly, so that more ventilators can be available for all critically ill patients.
Climbing suicide rates over the past ten years have prompted three Joint Commission Sentinel Event Alerts - the most recent in February 2016 - urging health care organizations to step up screening and detection of those individuals most at risk. But due to a shortage of both time and psychiatry staff, complying with this mandate presents a challenge.
The American Heart Association, with support from the Jon Holden DeHaan Foundation, has awarded funding for three research centers to study the development and mechanisms of generating new cardiac muscle cells.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
Promethera Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, announces today the completion of patient enrolment for its first clinical trial.
› Verified 5 days ago
| Preferred Hospice Of Missouri Location: 423 Business Highway 60 West Box 99, Dexter, Missouri, 63841 Phone: (573) 614-4774 |
| Missouri Delta Hospice Location: 1615 Business Highway 60 West, Suite A & B, Dexter, Missouri, 63841 Phone: (573) 614-4774 |
| Tri-county Hospice Services, Inc Location: Po Box 909, Dexter, Missouri, 63841 Phone: (573) 614-4774 |